Cargando…

Bovine adenovirus-3 as a vaccine delivery vehicle

The use of vaccines is an effective and relatively inexpensive means of controlling infectious diseases, which cause heavy economic losses to the livestock industry through animal loss, decreased productivity, treatment expenses and decreased carcass quality. However, some vaccines produced by conve...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayalew, Lisanework E., Kumar, Pankaj, Gaba, Amit, Makadiya, Niraj, Tikoo, Suresh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115382/
https://www.ncbi.nlm.nih.gov/pubmed/25498212
http://dx.doi.org/10.1016/j.vaccine.2014.11.055
_version_ 1783514085230379008
author Ayalew, Lisanework E.
Kumar, Pankaj
Gaba, Amit
Makadiya, Niraj
Tikoo, Suresh K.
author_facet Ayalew, Lisanework E.
Kumar, Pankaj
Gaba, Amit
Makadiya, Niraj
Tikoo, Suresh K.
author_sort Ayalew, Lisanework E.
collection PubMed
description The use of vaccines is an effective and relatively inexpensive means of controlling infectious diseases, which cause heavy economic losses to the livestock industry through animal loss, decreased productivity, treatment expenses and decreased carcass quality. However, some vaccines produced by conventional means are imperfect in many respects including virulence, safety and efficacy. Moreover, there are no vaccines for some animal diseases. Although genetic engineering has provided new ways of producing effective vaccines, the cost of production for veterinary use is a critical criterion for selecting the method of production and delivery of vaccines. The cost effective production and intrinsic ability to enter cells has made adenovirus vectors a highly efficient tool for delivery of vaccine antigens. Moreover, adenoviruses induce both humoral and cellular immune responses to expressed vaccine antigens. Since nonhuman adenoviruses are species specific, the development of animal specific adenoviruses as vaccine delivery vectors is being evaluated. This review summarizes the work related to the development of bovine adenovirus-3 as a vaccine delivery vehicle in animals, particularly cattle.
format Online
Article
Text
id pubmed-7115382
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71153822020-04-02 Bovine adenovirus-3 as a vaccine delivery vehicle Ayalew, Lisanework E. Kumar, Pankaj Gaba, Amit Makadiya, Niraj Tikoo, Suresh K. Vaccine Article The use of vaccines is an effective and relatively inexpensive means of controlling infectious diseases, which cause heavy economic losses to the livestock industry through animal loss, decreased productivity, treatment expenses and decreased carcass quality. However, some vaccines produced by conventional means are imperfect in many respects including virulence, safety and efficacy. Moreover, there are no vaccines for some animal diseases. Although genetic engineering has provided new ways of producing effective vaccines, the cost of production for veterinary use is a critical criterion for selecting the method of production and delivery of vaccines. The cost effective production and intrinsic ability to enter cells has made adenovirus vectors a highly efficient tool for delivery of vaccine antigens. Moreover, adenoviruses induce both humoral and cellular immune responses to expressed vaccine antigens. Since nonhuman adenoviruses are species specific, the development of animal specific adenoviruses as vaccine delivery vectors is being evaluated. This review summarizes the work related to the development of bovine adenovirus-3 as a vaccine delivery vehicle in animals, particularly cattle. Elsevier Ltd. 2015-01-15 2014-12-09 /pmc/articles/PMC7115382/ /pubmed/25498212 http://dx.doi.org/10.1016/j.vaccine.2014.11.055 Text en Copyright © 2014 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ayalew, Lisanework E.
Kumar, Pankaj
Gaba, Amit
Makadiya, Niraj
Tikoo, Suresh K.
Bovine adenovirus-3 as a vaccine delivery vehicle
title Bovine adenovirus-3 as a vaccine delivery vehicle
title_full Bovine adenovirus-3 as a vaccine delivery vehicle
title_fullStr Bovine adenovirus-3 as a vaccine delivery vehicle
title_full_unstemmed Bovine adenovirus-3 as a vaccine delivery vehicle
title_short Bovine adenovirus-3 as a vaccine delivery vehicle
title_sort bovine adenovirus-3 as a vaccine delivery vehicle
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115382/
https://www.ncbi.nlm.nih.gov/pubmed/25498212
http://dx.doi.org/10.1016/j.vaccine.2014.11.055
work_keys_str_mv AT ayalewlisaneworke bovineadenovirus3asavaccinedeliveryvehicle
AT kumarpankaj bovineadenovirus3asavaccinedeliveryvehicle
AT gabaamit bovineadenovirus3asavaccinedeliveryvehicle
AT makadiyaniraj bovineadenovirus3asavaccinedeliveryvehicle
AT tikoosureshk bovineadenovirus3asavaccinedeliveryvehicle